SPARING CYSTECTOMY IN PATIENTS WITH TRANSITIONAL-CELL CARCINOMA OF THE URINARY BLADDER

Por V. B. Matveyev, M. I. Volkova, K. M. Figurin, M. V. Peters
Publicado em 2009-03-01

Clinical experience with abiraterone acetate application in patients with castration-resistant prostate cancer

Por Ya V Gridneva, V B Matveev, D Z Kupchan, S A Kalinin, M V Peters
Publicado em 2014-09-01

LOCAL RECURRENCE OF TUBULOCYSTIC CARCINOMA 4 YEARS AFTER RENAL RESECTION (A CLINICAL OBSERVATION)

Por M. V. Peters, D. A. Roshchin, A. I. Karseladze, I. N. Sokolova, V. B. Matveev
Publicado em 2011-09-01

LOCAL RECURRENCE OF TUBULOCYSTIC CARCINOMA 4 YEARS AFTER RENAL RESECTION (A CLINICAL OBSERVATION)

Por M. V. Peters, D. A. Roshchin, A. I. Karseladze, I. N. Sokolova, V. B. Matveev
Publicado em 2011-09-01

Palliative nephrectomy until targeted therapy of disseminated kidney cancer patients

Por A. V. Klimov, M. I. Volkova, V. I. Shirokograd, S. A. Kalinin, M. V. Peters, V. B. Matveev
Publicado em 2015-09-01

Predictors of overall survival in patients with metastatic castration-resistant prostate cancer

Por A. S. Markova, S. B. Polikarpova, B. Sh. Kamolov, Ya. V. Gridneva, S. A. Kalinin, M. V. Peters, V. B. Matveev
Publicado em 2015-06-01

PROGNOSTIC VALUE OF MOLECULAR GENETIC MARKERS IN KIDNEY CANCER PATIENTS RECEIVING TARGETED THERAPY

Por M. V. Peters, V. E. Shevchenko, V. B. Matveev, M. I. Volkova, S. A. Kalinin, D. M. Mikhailenko, D. V. Zaletayev
Publicado em 2011-12-01

Impact of surgical volume on functional results and cardiospecific survival rates in patients with clinically localized renal cancer

Por M. I. Volkova, I. Ya. Skvortsov, A. V. Klimov, V. A. Chernyaev, M. I. Komarov, V. B. Matveev, M. V. Peters
Publicado em 2014-09-01

Molecular genetic diagnostics of clear cell renal cell carcinoma

Por N. V. Apanovich, M. V. Peters, A. A. Korotaeva, P. V. Apanovich, A. S. Markova, B. Sh. Kamolov, V. B. Matveev, A. V. Karpukhin
Publicado em 2016-12-01